Year Founded
1997
Ownership
Private
Employees
~35
Therapeutic Areas
Rare DiseasesNeurology
Stage
Commercial
Modalities
Other

Veriton Pharma General Information

Specializes in developing and manufacturing specialized medicinal products, particularly for epilepsy, neurology, and rare pediatric conditions. Has a portfolio of over 60 specialized formulations.

Contact Information

Website
Primary Industry
[ "Pharma" ]
Corporate Office
Weybridge,
United Kingdom

Drug Pipeline

Epistatus
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Veriton Pharma's pipeline data

Book a demo

Key Partnerships

SERB

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Veriton Pharma Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Veriton Pharma's complete valuation and funding history, request access »

Veriton Pharma Investors

SERB (acquirer)
Investor Type: Venture Capital
Holding: Minority